Novel monoclonal antibody can substantially lower triglycerides in patients with acute pancreatitis

(The Mount Sinai Hospital / Mount Sinai School of Medicine) The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai.